Newsroom
  • Press Releases
  • Presentations
Investors
  • Overview
  • Warrant Exercise Inquiries
  • Restricted Stock Inquiries
  • News / Events
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
Clinical Trial Enrollment
  • Triple-Negative Breast Cancer
  • COVID-19 Mild to Moderate
  • COVID-19 Severe or Critical
Contact

CytoDyn Inc.

  • Home
  • About CytoDyn
    • Meet CytoDyn
  • Our Science
  • Pipeline
    • Overview
    • HIV
    • Cancer
    • GVHD
    • COVID-19
  • Expanded Access
  • Our Team
    • Management Team
    • Board of Directors
  • Careers
    • Now Hiring
  • Scientific Board of Advisors
  • Newsroom
  • Investors
  • Clinical Trial Enrollment
  • Contact

FOR THE LATEST DEVELOPING NEWS

Click Here

Hospitals Enrolling COVID-19 Severe-to-Critical

Investment Community Webcast on Wednesday, January 6

Antibody-based strategies in HIV therapy

Dr. Seethamraju’s Presentation at Special isirv-AVG Virtual Conference

Manuscript Accepted by Infectious Diseases Society of America

Into the Looking Glass: Post-Viral Syndrome Post COVID-19

EUA for COVID-19 Vaccines and Treatments in the Philippines

Leronlimab’s Mechanism of Action in COVID-19 Published

Leronlimab role in COVID-19

Experimental Drugs Aim to Treat Long-Haul Covid Patients

Research on Critically Ill COVID-19 Patients Published in Journal of Translational Autoimmunity

Leronlimab and Long-Haulers

In The News

Investors

Investors

  • Overview
  • Warrant Exercise Inquiries
  • Restricted Stock Inquiries
  • News / Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • In The News
  • IR Calendar
  • Email Alerts

Coronavirus Live Question/Answer – Dr. Mike Hansen (Pulmonologist) and Dr. Yo (Anesthesiologist)

May 10, 2020

Doctor Mike Hansen – What doctors are learning from autopsy findings of coronavirus (COVID-19) patients

May 6, 2020

Proactive Investors: CytoDyn shares manuscript of potential coronavirus treatment to show validity of study's findings

May 6, 2020

NBC Palm Springs: HIV Treatment to be Tested on Covid-19 Patients

May 5, 2020

Proactive Investors: CytoDyn expects to fully enroll its trials to treat coronavirus patients by end of May

May 4, 2020

USA Today Post: Mum fighting triple cancer allowed to fly to USA despite virus travel ban

May 3, 2020

Fox News: Eric Shawn: Coronavirus, the answer may be in your genes

May 3, 2020

Daily Kos: The good news: Treatments and vaccines are coming that really could turn the tide in 2020

May 2, 2020

Wall Street Reporter: Next Super Stock CytoDyn (OTC:CYDY) Livestream: COVID-19 Coronavirus treatment clinical data update

May 1, 2020

Dr. Yo – Is Leronlimab a Game Changer? Coronavirus (COVID-19) Treatment | How does Leronlimab work?

May 1, 2020
RSS
  • « Previous
  • 1...
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • ...13
  • Next »
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2021 CytoDyn Inc. All Rights Reserved.
  • Twitter
  • Facebookj
Privacy Policy Disclaimer Sitemap